Systemic Vascular Resistance

[1]  K. A. Hale,et al.  Effects of vasodilators on pulmonary hemodynamics and gas exchange in left ventricular failure. , 1980, American heart journal.

[2]  J. Cohn,et al.  Nitrate effects on cardiac output and left ventricular outflow resistance in chronic congestive heart failure. , 1978, The American journal of medicine.

[3]  J. Cohn,et al.  Contrasting effect of vasodilators on heart rate and plasma catecholamines in patients with hypertension and heart failure , 1978 .

[4]  J. Cohn,et al.  Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. , 1977, Annals of internal medicine.

[5]  J. Cohn,et al.  Stimulation of Vascular Smooth Muscle Sodium, Potassium—Adenosinetriphosphatase by Vasodilators , 1974, Circulation research.

[6]  J. Cohn,et al.  Treatment of refractory heart failure with infusion of nitroprusside. , 1974, The New England journal of medicine.

[7]  F. Haddy.  Local Control of Vascular Resistance: as Related to Hypertension , 1974 .

[8]  J. Mcgiff,et al.  Prostaglandins and the Kidney , 1973, Circulation research.

[9]  J. O. Davis.  The control of renin release. , 1973, The American journal of medicine.

[10]  J. Laragh.  Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. , 1973, The American journal of medicine.

[11]  J. Cohn.  Vasodilator Therapy for Heart Failure: The Influence of Impedance on Left Ventricular Performance , 1973, Circulation.

[12]  B. Pitt,et al.  Use of Phentolamine in Acute Myocardial Infarction Associated with Hypertension and Left Ventricular Failure , 1973, Circulation.

[13]  M. Mendlowitz.  Vascular reactivity in systemic arterial hypertension. , 1973, American heart journal.

[14]  R. A. Norman,et al.  Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. , 1972, The American journal of medicine.

[15]  A. Sjoerdsma,et al.  Altered urinary kallikrein excretion in human hypertension. , 1971, Lancet.

[16]  E. Sonnenblick,et al.  Myocardial energetics: basic principles and clinical implications. , 1971, The New England journal of medicine.

[17]  E. Sonnenblick.  Non-invasive evaluation of regional ventricular dysfunction. , 1971, The New England journal of medicine.

[18]  J. Mackenzie,et al.  Plasma Renin in Chronic Experimental Heart Failure and during Renal Sodium “Escape” from Mineralocorticoids , 1968, Circulation research.

[19]  J. Cohn.  Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man. , 1966, Clinical science.

[20]  E. Braunwald,et al.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.

[21]  J. Ross,et al.  The Study of Left Ventricular Function in Man by Increasing Resistance to Ventricular Ejection with Angiotensin , 1964, Circulation.

[22]  D. Rodbard,et al.  Myocardial Tension and Oxygen Uptake , 1964, Circulation research.

[23]  L. Tobian.  Interrelationship of electrolytes, juxtaglomerular cells and hypertension. , 1960, Physiological reviews.

[24]  E. Freis.  Hemodynamics of hypertension. , 1960, Physiological reviews.

[25]  J. H. Green,et al.  Baroceptor Function in Chronic Renal Hypertension , 1956, Circulation research.

[26]  E BERGLUND,et al.  Ventricular Function: I. Starling's Law of the Heart Studied by Means of Simultaneous Right and Left Ventricular Function Curves in the Dog , 1954, Circulation.